ACOG
Alpha Cognition Inc

332
Loading...
Loading...
Alpha Cognition, Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. It has additional pre-clinical development programs: ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer’s disease, ALPHA-1062 sublingual formulation, ALPHA-1062 intranasal (“ALPHA-1062IN”) formulation for the treatment of cognitive impairment with mild traumatic brain injury (mTBI, otherwise known as concussion) and ALPHA-0602, ALPHA-0702 & ALPHA-0802. The company was founded in 2000 and is headquartered in Grapevine, TX.
Sector:
Finance
Industry:
Financial Conglomerates
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Alpha Cognition Inc?
What is the 52-week high for Alpha Cognition Inc?
What is the 52-week low for Alpha Cognition Inc?
What is Alpha Cognition Inc stock price today?
What was Alpha Cognition Inc stock price yesterday?
What is the PE ratio of Alpha Cognition Inc?
What is the Price-to-Book ratio of Alpha Cognition Inc?
What is the 50-day moving average of Alpha Cognition Inc?

Latest ACOG News

View

Advertisement. Remove ads.

Advertisement. Remove ads.